What is the official website of Clone Screening | Molecular Devices ?

The official website of Clone Screening | Molecular Devices is https://www.moleculardevices.com/products/clone-screening.

What is Clone Screening | Molecular Devices's cybersecurity risk score?

Clone Screening | Molecular Devices has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Clone Screening | Molecular Devices experienced?

According to Rankiteo, Clone Screening | Molecular Devices currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Clone Screening | Molecular Devices been affected by any supply chain cyber incidents ?

According to Rankiteo, Clone Screening | Molecular Devices has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Clone Screening | Molecular Devices have SOC 2 Type 1 certification ?

According to Rankiteo, Clone Screening | Molecular Devices is not certified under SOC 2 Type 1.

Does Clone Screening | Molecular Devices have SOC 2 Type 2 certification ?

According to Rankiteo, Clone Screening | Molecular Devices does not hold a SOC 2 Type 2 certification.

Does Clone Screening | Molecular Devices comply with GDPR ?

According to Rankiteo, Clone Screening | Molecular Devices is not listed as GDPR compliant.

Does Clone Screening | Molecular Devices have PCI DSS certification ?

According to Rankiteo, Clone Screening | Molecular Devices does not currently maintain PCI DSS compliance.

Does Clone Screening | Molecular Devices comply with HIPAA ?

According to Rankiteo, Clone Screening | Molecular Devices is not compliant with HIPAA regulations.

Does Clone Screening | Molecular Devices have ISO 27001 certification ?

According to Rankiteo,Clone Screening | Molecular Devices is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Clone Screening | Molecular Devices operate in ?

Clone Screening | Molecular Devices operates primarily in the Biotechnology Research industry.

How many employees does Clone Screening | Molecular Devices have ?

Clone Screening | Molecular Devices employs approximately None employees people worldwide.

Does Clone Screening | Molecular Devices own any subsidiaries ?

Clone Screening | Molecular Devices presently has no subsidiaries across any sectors.

How many LinkedIn followers does Clone Screening | Molecular Devices have ?

Clone Screening | Molecular Devices's official LinkedIn profile has approximately 1,065 followers.

What is the NAICS classification code for Clone Screening | Molecular Devices ?

Clone Screening | Molecular Devices is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Clone Screening | Molecular Devices have a Crunchbase profile ?

No, Clone Screening | Molecular Devices does not have a profile on Crunchbase.

Does Clone Screening | Molecular Devices have a LinkedIn profile ?

Yes, Clone Screening | Molecular Devices maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/molecular-devices-clone-screening.

How many cybersecurity incidents has Clone Screening | Molecular Devices experienced ?

As of July 24, 2026, Rankiteo reports that Clone Screening | Molecular Devices has not experienced any cybersecurity incidents.

How many peer or competitor companies does Clone Screening | Molecular Devices have ?

Clone Screening | Molecular Devices has an estimated 4,731 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

CSMD

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

Clone Screening | Molecular Devices Vendor Cyber Rating & Cyber Score

moleculardevices.com

Add Your Compliance Badge

Our solutions for antibody discovery and cell line development provide dedicated, scalable, and easy-to-use products for establishing clonal populations. The systems feature a selection of options and models to address your specific research including multiple imaging modes, biology-specific pins, fluidics, and environmental control. These solutions combine intelligent imaging with analysis and automation to increase throughput, consistency, and provide image-based documentation.

CSMD A.I CyberSecurity Scoring

Scoring History

CSMD

Clone Screening | Molecular Devices CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

CSMD Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for CSMD

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Clone Screening | Molecular Devices in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Clone Screening | Molecular Devices in 2026.

Incident Types CSMD vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Clone Screening | Molecular Devices in 2026.

Incident History - CSMD (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Clone Screening | Molecular Devices Subsidiaries

CSMD

Biotechnology Research

Website: https://www.moleculardevices.com/products/clone-screening

Company Size: 1,001-5,000 employees

Danaher CorporationMedical Equipment Manufacturing

Beckman Coulter DiagnosticsMedical Equipment Manufacturing

Beckman Coulter Dx North AmericaMedical Equipment Manufacturing

Beckman Coulter Dx BrasilFabricação de instrumentos e materiais para uso médico e odontológico e de artigos ópticos

Beckman Coulter Dx EEMEAتصنيع المعدات الطبية

Beckman Coulter Dx LATAMFabricação de instrumentos e materiais para uso médico e odontológico e de artigos ópticos

Beckman Coulter Dx Asia PacificMedical Equipment Manufacturing

한국벡크만쿨터의료장비 제조

CytivaBiotechnology Research

Pall Medical, part of CytivaMedical Equipment Manufacturing

Cytiva LATAMPesquisa biotecnológica

Pall CorporationManufacturing

Aria FiltraEnvironmental Services

Pall - Energy+Machinery Manufacturing

Pall - Food & BeverageFood and Beverage Services

Pall - Energy+Machinery Manufacturing

Pall - AerospaceAviation and Aerospace Component Manufacturing

Pall - MicroelectronicsAppliances, Electrical, and Electronics Manufacturing

Leica MicrosystemsMedical Equipment Manufacturing

Leica Microsystems MedicalHospitals and Health Care

Beckman Coulter Life SciencesBiotechnology Research

Beckman Coulter Life Sciences India, SWA, METAIBiotechnology Research

Beckman Coulter Life Sciences BrazilBiotechnology Research

Beckman Coulter Life Sciences LATAMBiotechnology Research

Beckman Coulter Life Sciences TASK RegionBiotechnology Research

Beckman Coulter Life Sciences - China生物技术研究

Beckman Coulter Life Sciences RussiaИсследования в сфере биотехнологий

CepheidBiotechnology Research

SCIEXBiotechnology

SCIEX Food & Environmental Testing SolutionsBiotechnology Research

SCIEX LatinoaméricaPesquisa biotecnológica

SCIEX Omics SolutionsBiotechnology

SCIEX Forensic Testing SolutionsBiotechnology Research

SCIEX Biopharma & Pharma SolutionsBiotechnology Research

SCIEX Service & SupportMedical Equipment Manufacturing

SCIEX Clinical ApplicationsMedical Equipment Manufacturing

Leica BiosystemsMedical Device

abcamBiotechnology Research

Integrated DNA TechnologiesBiotechnology Research

CRISPR genome editing by IDTBiotechnology Research

MammotomeMedical Equipment Manufacturing

HemoCue ABMedical Equipment Manufacturing

Danaher Life SciencesBiotechnology Research

GenedataBiotechnology Research

ジーンデータ（株）/ Genedata KKバイオテクノロジー研究

RadiometerMedical Equipment Manufacturing

PhenomenexBiotechnology Research

Phenomenex - EMEABiotechnology

IDBSSoftware Development

PolarSoftware Development

AldevronBiotechnology Research

Beckman Coulter Diagnostics EuropeMedical Equipment Manufacturing

Beckman Coulter Dx India & SWAMedical Equipment Manufacturing

Danaher India Development CenterIT System Custom Software Development

Beckman Coulter Dx Eastern EuropeVýroba zdravotnických prostředků

Beckman Coulter Dx TurkeyTıbbi Ekipman İmalatı

Beckman Coulter Dx China生物技术研究

Danaher DiagnosticsMedical Equipment Manufacturing

Molecular DevicesBiotechnology Research

Molecular Devices IndiaBiotechnology Research

High-Content Imaging | Molecular DevicesBiotechnology Research

High-Content Imaging & Analysis | Molecular DevicesBiotechnology Research

Axon Patch-Clamp | Molecular DevicesBiotechnology Research

3D Biology | Molecular DevicesBiotechnology Research

Loading…

Clone Screening | Molecular Devices Similar Companies

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

Loading…

NEWS

Clone Screening | Molecular Devices CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

August 28, 2025 07:00 AM

Canadians caught in crossfire as U.S. customs searches of electronic devices rise at borders

U.S. Customs and Border Protection (CBP) reports a sharp rise in electronic device searches at crossings, raising concerns about privacy,...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-50044

SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.

Published

Date2026-07-23

Updated

Date2026-07-23

RISK INFORMATION (Score: 6.8)

cvss3

Base Score: 6.8

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:N

cvss4

Base Score: 7.6

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

1.6

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

CVE-2026-44955

SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.

Published

Date2026-07-23

Updated

Date2026-07-23

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

CVE-2026-42933

SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

Published

Date2026-07-23

Updated

Date2026-07-23

RISK INFORMATION (Score: 10)

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 10.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

CVE-2026-40430

SUMMARY

Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.

Published

Date2026-07-23

Updated

Date2026-07-23

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

CVE-2026-28698

SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.

Published

Date2026-07-23

Updated

Date2026-07-23

RISK INFORMATION (Score: 8.6)

cvss3

Base Score: 8.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…